Skip to main content
SpringerLink
Log in

Earlier discovery of pregabalin’s dependence potential might have been possible

  • Letter to the Editors
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Drug Enforcement Administration, Department of Justice (2005) Schedules of controlled substances: placement of pregabalin into schedule V. Fed Regist 70(144):43633–43635

    Google Scholar 

  2. European Medicines Agency (EMA). Lyrica – Procedural steps taken after authorisation. Available from: www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Procedural_steps_taken_and_scientific_information_after_authorisation/human/000546/WC500046604.pdf. Accessed 26th August 2010.

  3. Schwan S, Sundström A, Stjernberg E, Hallberg E, Hallberg P (2010) A signal for abuse potential for pregabalin – results from the Swedish spontaneous adverse reaction reporting system. Eur J Clin Pharmacol 66:947–953

    Article  PubMed  Google Scholar 

  4. Caster O, Kindlundh-Högberg A, Hopstadius J, Norén GN (2010) Early indicators of drug dependence. Pharmacoepidem Dr S 19(S1):S224–S225

    Google Scholar 

Download references

Conflicts of interest

The findings presented in this letter were enabled by the results of a methodologically oriented project aimed at identifying drug dependence indicators on individual case safety reports. This methodological project, in turn, received funding by the EU-FP7 project MONITORING MEDICINES (grant number 223566). The funding source had no involvement in any parts of the production of this letter.

Author information

Authors and Affiliations

  1. Uppsala Monitoring Centre, WHO Collaborating Centre for International Drug Monitoring, Box 1051, 75140, Uppsala, Sweden

    Ola Caster, I. Ralph Edwards, G. Niklas Norén & Marie Lindquist

Authors
  1. Ola Caster
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I. Ralph Edwards
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Niklas Norén
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marie Lindquist
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ola Caster.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Caster, O., Edwards, I.R., Norén, G.N. et al. Earlier discovery of pregabalin’s dependence potential might have been possible. Eur J Clin Pharmacol 67, 319–320 (2011). https://doi.org/10.1007/s00228-010-0920-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-010-0920-4

Keywords

Search

Navigation